ஸ்தாபனம் ஆய்வகங்கள் ஹோல்டிங்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஸ்தாபனம் ஆய்வகங்கள் ஹோல்டிங்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஸ்தாபனம் ஆய்வகங்கள் ஹோல்டிங்ஸ் Today - Breaking & Trending Today

BTIG Keeps a Buy Rating on Accuray (ARAY)


Markets
In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Accuray (ARAY – Research Report), with a price target of $9.00. The company’s shares closed last Tuesday at $5.32, close to its 52-week high of $6.02.
According to TipRanks.com, Thibault is a 5-star analyst with an average return of 74.2% and a 64.9% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Irhythm Technologies, and Edwards Lifesciences.
Accuray has an analyst consensus of Moderate Buy, with a price target consensus of $8.00.
The company has a one-year high of $6.02 and a one-year low of $1.75. Currently, Accuray has an average volume of 790.2K. ....

Johnr Adler , Marie Thibault , Edwards Lifesciences , Accuray Inc , Establishment Labs Holdings , Research Report , Irhythm Technologies , Moderate Buy , மேரி திபோுல்ட் , எட்வர்ட்ஸ் ஆயுள் அறிவியல் , அச்சுறய இன்க் , ஸ்தாபனம் ஆய்வகங்கள் ஹோல்டிங்ஸ் , ஆராய்ச்சி அறிக்கை , மிதமான வாங்க ,

Masimo (MASI) Receives a Hold from BTIG


Markets
In a report released yesterday, Marie Thibault from BTIG maintained a Hold rating on Masimo (MASI – Research Report). The company’s shares closed last Monday at $242.67.
According to TipRanks.com, Thibault is a 5-star analyst with an average return of 74.1% and a 61.5% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies.
Masimo has an analyst consensus of Moderate Buy, with a price target consensus of $297.50, implying a 20.3% upside from current levels. In a report issued on April 12, Needham also assigned a Hold rating to the stock.
Based on Masimo’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $295 million and net profit of $70.67 million. In comparison, last year the company earned revenue of $248 million and had a net profit of $52.92 million. ....

Joee Kiani , Marie Thibault , Edwards Lifesciences , Masimo Corp , Establishment Labs Holdings , Research Report , Moderate Buy , மேரி திபோுல்ட் , எட்வர்ட்ஸ் ஆயுள் அறிவியல் , மசிமோ கார்ப் , ஸ்தாபனம் ஆய்வகங்கள் ஹோல்டிங்ஸ் , ஆராய்ச்சி அறிக்கை , மிதமான வாங்க ,